These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 12584256)

  • 1. A beta-catenin survival signal is required for normal lobular development in the mammary gland.
    Tepera SB; McCrea PD; Rosen JM
    J Cell Sci; 2003 Mar; 116(Pt 6):1137-49. PubMed ID: 12584256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted activation of beta-catenin signaling in basal mammary epithelial cells affects mammary development and leads to hyperplasia.
    Teulière J; Faraldo MM; Deugnier MA; Shtutman M; Ben-Ze'ev A; Thiery JP; Glukhova MA
    Development; 2005 Jan; 132(2):267-77. PubMed ID: 15590737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twist is up-regulated in response to Wnt1 and inhibits mouse mammary cell differentiation.
    Howe LR; Watanabe O; Leonard J; Brown AM
    Cancer Res; 2003 Apr; 63(8):1906-13. PubMed ID: 12702582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delta N89 beta-catenin induces precocious development, differentiation, and neoplasia in mammary gland.
    Imbert A; Eelkema R; Jordan S; Feiner H; Cowin P
    J Cell Biol; 2001 Apr; 153(3):555-68. PubMed ID: 11331306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mammary gland development requires syndecan-1 to create a beta-catenin/TCF-responsive mammary epithelial subpopulation.
    Liu BY; Kim YC; Leatherberry V; Cowin P; Alexander CM
    Oncogene; 2003 Dec; 22(58):9243-53. PubMed ID: 14681683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor and secreted targets of Wnt-1/beta-catenin signalling in mouse mammary epithelial cells.
    Kenny PA; Enver T; Ashworth A
    BMC Cancer; 2005 Jan; 5():3. PubMed ID: 15642117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis.
    Hollmann CA; Kittrell FS; Medina D; Butel JS
    Oncogene; 2001 Nov; 20(52):7645-57. PubMed ID: 11753642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-catenin and Tcfs in mammary development and cancer.
    Hatsell S; Rowlands T; Hiremath M; Cowin P
    J Mammary Gland Biol Neoplasia; 2003 Apr; 8(2):145-58. PubMed ID: 14635791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of genes differentially expressed in mouse mammary epithelium transformed by an activated beta-catenin.
    Renou JP; Bierie B; Miyoshi K; Cui Y; Djiane J; Reichenstein M; Shani M; Hennighausen L
    Oncogene; 2003 Jul; 22(29):4594-610. PubMed ID: 12881717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive overexpression of Id-1 in mammary glands of transgenic mice results in precocious and increased formation of terminal end buds, enhanced alveologenesis, delayed involution.
    Shin DH; Jang SH; Kang BC; Kim HJ; Oh SH; Kong G
    J Cell Physiol; 2011 May; 226(5):1340-52. PubMed ID: 20945346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the canonical Wnt/beta-catenin pathway confers growth advantages in c-Myc/E2F1 transgenic mouse model of liver cancer.
    Calvisi DF; Conner EA; Ladu S; Lemmer ER; Factor VM; Thorgeirsson SS
    J Hepatol; 2005 Jun; 42(6):842-9. PubMed ID: 15885355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted expression of the dominant-negative prolactin receptor in the mammary gland of transgenic mice results in impaired lactation.
    Saunier E; Dif F; Kelly PA; Edery M
    Endocrinology; 2003 Jun; 144(6):2669-75. PubMed ID: 12746331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression and forced activation of stat5 in mammary gland of transgenic mice promotes cellular proliferation, enhances differentiation, and delays postlactational apoptosis.
    Iavnilovitch E; Groner B; Barash I
    Mol Cancer Res; 2002 Nov; 1(1):32-47. PubMed ID: 12496367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a mouse homolog of the human BTEB2 transcription factor as a beta-catenin-independent Wnt-1-responsive gene.
    Ziemer LT; Pennica D; Levine AJ
    Mol Cell Biol; 2001 Jan; 21(2):562-74. PubMed ID: 11134343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor receptor: a novel target of the Wnt/beta-catenin pathway in liver.
    Tan X; Apte U; Micsenyi A; Kotsagrelos E; Luo JH; Ranganathan S; Monga DK; Bell A; Michalopoulos GK; Monga SP
    Gastroenterology; 2005 Jul; 129(1):285-302. PubMed ID: 16012954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of different Wnt/beta-catenin signaling components in mammary epithelium induces transdifferentiation and the formation of pilar tumors.
    Miyoshi K; Rosner A; Nozawa M; Byrd C; Morgan F; Landesman-Bollag E; Xu X; Seldin DC; Schmidt EV; Taketo MM; Robinson GW; Cardiff RD; Hennighausen L
    Oncogene; 2002 Aug; 21(36):5548-56. PubMed ID: 12165853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. beta-catenin is a downstream effector of Wnt-mediated tumorigenesis in the mammary gland.
    Michaelson JS; Leder P
    Oncogene; 2001 Aug; 20(37):5093-9. PubMed ID: 11526497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin.
    Kolligs FT; Kolligs B; Hajra KM; Hu G; Tani M; Cho KR; Fearon ER
    Genes Dev; 2000 Jun; 14(11):1319-31. PubMed ID: 10837025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of the tumor suppressor gene phosphatase and tensin homologue partially inhibits wnt-1-induced mammary tumorigenesis.
    Zhao H; Cui Y; Dupont J; Sun H; Hennighausen L; Yakar S
    Cancer Res; 2005 Aug; 65(15):6864-73. PubMed ID: 16061670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human chorionic gonadotropin (hCG) up-regulates wnt5b and wnt7b in the mammary gland, and hCGbeta transgenic female mice present with mammary Gland tumors exhibiting characteristics of the Wnt/beta-catenin pathway activation.
    Kuorelahti A; Rulli S; Huhtaniemi I; Poutanen M
    Endocrinology; 2007 Aug; 148(8):3694-703. PubMed ID: 17510243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.